Analyst Consensus ?
ConsensusHold27 ratings
Bullish1555.6%
Neutral933.3%
Bearish311.1%
Palantir Technologies Inc. · PLTR · FY2026 Q3 · Calendar Q4 2026
Palantir raises FY2026 outlook as revenue growth accelerates
The quarter strengthens the case that demand for Palantir’s AI workflow products is translating into rapid growth and expanded guidance. Whether that momentum can persist depends on converting current adoption into durable contracts while managing expenses and customer concentration.
Reported After market closeNASDAQTechnology
$410.31B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.44
Consensus $0.41
EPS surprise
+8.3%
Reported versus consensus
Reported revenue
$2.31B
Consensus $2.18B
Revenue surprise
+6.3%
Reported versus consensus
Market reaction
close-to-close (session unavailable)
Stock move
-3.1%
Event window
SPY move
-0.5%
Same window
Abnormal move
-2.7%
Stock minus SPY
Volume
1.6×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
PLTRSPY benchmark
Ask FN2 about PLTR FY2026 Q3
Transcript, numbers and history already loaded
Why did PLTR fall 3.1% after beating EPS estimates in FY2026 Q3?What changed in PLTR's guidance and outlook in FY2026 Q3?Give me the bull and bear case for PLTR after FY2026 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter’s already strong growth and raised outlook, management reported faster year-over-year revenue growth, continued expansion in U.S. commercial business, and another increase to full-year guidance. U.S. commercial revenue exceeded U.S. government revenue for the first time, according to the supplied analysis.
Guidance delta
Management raised full-year 2026 revenue and U.S. commercial revenue guidance again. The supplied analysis reports the revenue range as $8.53–$8.53 billion; no further interpretation of that range is warranted here.
Key takeaways
- Revenue grew 96% year over year to $2.313 billion, according to the supplied analysis.
- U.S. commercial revenue grew 148% year over year and exceeded U.S. government revenue for the first time.
- Management raised full-year 2026 revenue and U.S. commercial revenue guidance.
- Management highlighted Sovereign AI, AIP workflow automation, and bootcamp conversion as demand drivers.
Management priorities
- Scale Sovereign AI bootcamps and convert short-duration engagements into larger contracts.
- Advance AutoResearch and AIP Evolve for model improvement.
- Deploy DORA for edge and space use cases and expand Maven capabilities.
Follow PLTR with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$178.34Previous close
$4.5Low
$148.12Average
$265High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Nov 3, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Nov 2, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Oct 29, 2026 |
| Rosenblatt | Buy | Buy | Maintain | Oct 27, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Oct 23, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 22, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Oct 15, 2026 |
| Goldman Sachs | Buy | Neutral | Upgrade | Oct 8, 2026 |
| UBS | Buy | Buy | Maintain | Sep 15, 2026 |
| DA Davidson | Buy | Buy | Maintain | Sep 11, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | Aug 4, 2026 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Jun 16, 2026 |
| Wedbush | Outperform | Outperform | Maintain | Jun 5, 2026 |
| Argus Research | Buy | Hold | Upgrade | May 6, 2026 |
| RBC Capital | Underperform | Underperform | Maintain | May 5, 2026 |
| HSBC | Hold | Buy | Downgrade | May 1, 2026 |
| Freedom Broker | Buy | Sell | Upgrade | Feb 13, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Nov 4, 2025 |
| Baird | Neutral | Neutral | Maintain | Nov 4, 2025 |
| B of A Securities | Buy | Buy | Maintain | Nov 4, 2025 |
| Loop Capital | Buy | Buy | Maintain | Aug 5, 2025 |
| William Blair | Market Perform | Underperform | Upgrade | Mar 5, 2025 |
| Northland Capital Markets | Market Perform | Market Perform | Maintain | Feb 4, 2025 |
| Jefferies | Underperform | Underperform | Maintain | Feb 4, 2025 |
| Benchmark | Buy | Buy | Maintain | Dec 20, 2024 |
| Raymond James | Market Perform | Outperform | Downgrade | Sep 23, 2024 |
| Monness, Crespi, Hardt | Sell | Neutral | Downgrade | Jun 21, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | May 10, 2023 |
Named analyst price targets
Upside is calculated against the persisted previous close $178.34. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Oppenheimer | Analyst unavailable | $235 | $196.81 | +31.8% | Oct 29, 2026 |
| Rosenblatt Securities | John McPeake | $260 | $198.84 | +45.8% | Oct 27, 2026 |
| Deutsche Bank | Brad Zelnick | $225 | $198.62 | +26.2% | Oct 26, 2026 |
| Piper Sandler | Analyst unavailable | $231 | $196.19 | +29.5% | Oct 23, 2026 |
| Mizuho Securities | Gregg Moskowitz | $245 | $200.97 | +37.4% | Oct 15, 2026 |
| Robert W. Baird | William Power | $250 | $209.05 | +40.2% | Oct 12, 2026 |
| Barclays | Anthony Valentini | $265 | $198.78 | +48.6% | Oct 8, 2026 |
| Goldman Sachs | Gabriela Borges | $230 | $194.12 | +29.0% | Oct 8, 2026 |
| UBS | Analyst unavailable | $250 | $173.31 | +40.2% | Sep 15, 2026 |
| D.A. Davidson | Gil Luria | $250 | $168.03 | +40.2% | Sep 11, 2026 |
| UBS | Analyst unavailable | $215 | $175.23 | +20.6% | Aug 11, 2026 |
| Northland Securities | Analyst unavailable | $200 | $158.09 | +12.1% | Aug 4, 2026 |
| Mizuho Securities | Gregg Moskowitz | $215 | $153.91 | +20.6% | Aug 4, 2026 |
| Goldman Sachs | Analyst unavailable | $204 | $125.65 | +14.4% | Aug 4, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $156 | $125.65 | -12.5% | Aug 4, 2026 |
| D.A. Davidson | Gil Luria | $200 | $125.65 | +12.1% | Aug 4, 2026 |
| Jefferies | Brent Thill | $80 | $125.65 | -55.1% | Aug 4, 2026 |
| RBC Capital | Rishi Jaluria | $90 | $121.72 | -49.5% | Jul 31, 2026 |
| D.A. Davidson | Analyst unavailable | $175 | $125.73 | -1.9% | Jul 2, 2026 |
| UBS | Karl Keirstead | $200 | $129.98 | +12.1% | Jun 16, 2026 |
| Cantor Fitzgerald | Thomas Blakey | $138 | $137.42 | -22.6% | May 22, 2026 |
| Argus Research | Analyst unavailable | $190 | $135.91 | +6.5% | May 6, 2026 |
| D.A. Davidson | Analyst unavailable | $165 | $137.31 | -7.5% | May 5, 2026 |
| HSBC | Analyst unavailable | $151 | $144.07 | -15.3% | May 1, 2026 |
| Oppenheimer | Param Singh | $200 | $137.97 | +12.1% | Apr 30, 2026 |
| Mizuho Securities | Gregg Moskowitz | $185 | $132.37 | +3.7% | Apr 14, 2026 |
| Daiwa | Analyst unavailable | $180 | $142.91 | +0.9% | Feb 10, 2026 |
| Deutsche Bank | Brad Zelnick | $200 | $155.6 | +12.1% | Feb 3, 2026 |
| HSBC | Analyst unavailable | $205 | $156.07 | +14.9% | Feb 3, 2026 |
| D.A. Davidson | Analyst unavailable | $180 | $154.46 | +0.9% | Feb 3, 2026 |
| Northland Securities | Analyst unavailable | $190 | $147.76 | +6.5% | Feb 3, 2026 |
| UBS | Analyst unavailable | $180 | $147.76 | +0.9% | Feb 3, 2026 |
| Mizuho Securities | Analyst unavailable | $195 | $147.76 | +9.3% | Feb 3, 2026 |
| Piper Sandler | Analyst unavailable | $230 | $147.76 | +29.0% | Feb 3, 2026 |
| Jefferies | Analyst unavailable | $208 | $165.33 | +16.6% | Jan 22, 2026 |
| Truist Financial | Analyst unavailable | $223 | $174.04 | +25.0% | Jan 6, 2026 |
| Cantor Fitzgerald | Thomas Blakey | $198 | $192.26 | +11.0% | Nov 4, 2025 |
| D.A. Davidson | Analyst unavailable | $215 | $192.67 | +20.6% | Nov 4, 2025 |
| Morgan Stanley | Analyst unavailable | $205 | $192.29 | +14.9% | Nov 4, 2025 |
| Goldman Sachs | Analyst unavailable | $188 | $192.06 | +5.4% | Nov 4, 2025 |
| UBS | Karl Keirstead | $205 | $207.18 | +14.9% | Nov 4, 2025 |
| Robert W. Baird | William Power | $200 | $207.18 | +12.1% | Nov 4, 2025 |
| Mizuho Securities | Gregg Moskowitz | $205 | $207.18 | +14.9% | Nov 4, 2025 |
| Piper Sandler | Analyst unavailable | $201 | $177.21 | +12.7% | Oct 14, 2025 |
| Mizuho Securities | Analyst unavailable | $165 | $171.43 | -7.5% | Sep 15, 2025 |
| Wedbush | Daniel Ives | $200 | $173.27 | +12.1% | Aug 5, 2025 |
| Morgan Stanley | Analyst unavailable | $155 | $173.27 | -13.1% | Aug 5, 2025 |
| Piper Sandler | Brent Bracelin | $182 | $173.27 | +2.1% | Aug 5, 2025 |
| D.A. Davidson | Gil Luria | $170 | $173.27 | -4.7% | Aug 5, 2025 |
| Loop Capital Markets | Analyst unavailable | $180 | $173.27 | +0.9% | Aug 5, 2025 |
| UBS | Analyst unavailable | $165 | $173.27 | -7.5% | Aug 5, 2025 |
| Deutsche Bank | Brad Zelnick | $160 | $173.27 | -10.3% | Aug 5, 2025 |
| Wedbush | Daniel Ives | $160 | $142.5 | -10.3% | Jul 10, 2025 |
| Loop Capital Markets | Mark Schappel | $155 | $135.19 | -13.1% | Jun 12, 2025 |
| Mizuho Securities | Matthew Broome | $94 | $108.86 | -47.3% | May 6, 2025 |
| D.A. Davidson | Gil Luria | $115 | $108.86 | -35.5% | May 6, 2025 |
| Loop Capital Markets | Mark Schappel | $130 | $108.86 | -27.1% | May 6, 2025 |
| Wedbush | Daniel Ives | $140 | $106.38 | -21.5% | May 6, 2025 |
| William Blair | Analyst unavailable | $84 | $90.13 | -52.9% | Mar 5, 2025 |
| D.A. Davidson | Gil Luria | $105 | $103.83 | -41.1% | Feb 4, 2025 |
| Mizuho Securities | Gregg Moskowitz | $80 | $103.83 | -55.1% | Feb 4, 2025 |
| Morgan Stanley | Sanjit Singh | $95 | $103.83 | -46.7% | Feb 4, 2025 |
| Jefferies | Brent Thill | $60 | $103.83 | -66.4% | Feb 4, 2025 |
| Wedbush | Dan Ives | $75 | $64.35 | -57.9% | Nov 25, 2024 |
| Wedbush | Dan Ives | $57 | $51.02 | -68.0% | Nov 5, 2024 |
| D.A. Davidson | Gil Luria | $47 | $51.02 | -73.6% | Nov 5, 2024 |
| Wedbush | Daniel Ives | $45 | $37.12 | -74.8% | Sep 26, 2024 |
| Bank of America Securities | Mariana Perez Mora | $50 | $35.88 | -72.0% | Sep 16, 2024 |
| Northland Securities | Michael Latimore | $35 | $32.59 | -80.4% | Aug 22, 2024 |
| Citigroup | Tyler Radke | $30 | $29.28 | -83.2% | Aug 8, 2024 |
| Goldman Sachs | Gabriela Borges | $16 | $26.59 | -91.0% | Aug 6, 2024 |
| Bank of America Securities | Mariana Perez Mora | $30 | $26.92 | -83.2% | Aug 6, 2024 |
| Wedbush | Dan Ives | $38 | $26.82 | -78.7% | Aug 6, 2024 |
| D.A. Davidson | Gil Luria | $28 | $24.09 | -84.3% | Aug 6, 2024 |
| Wedbush | Daniel Ives | $50 | $28.9 | -72.0% | Jul 18, 2024 |
| Argus Research | Joseph Bonner | $29 | $23.57 | -83.7% | Jun 17, 2024 |
| Mizuho Securities | Gregg Moskowitz | $21 | $21.6 | -88.2% | May 7, 2024 |
| D.A. Davidson | Gil Luria | $24 | $21.7 | -86.5% | May 7, 2024 |
| Deutsche Bank | Brad Zelnick | $20 | $25.21 | -88.8% | May 7, 2024 |
| Wedbush | Dan Ives | $35 | $23.33 | -80.4% | May 6, 2024 |
| Jefferies | Brent Thill | $22 | $21.87 | -87.7% | Feb 6, 2024 |
| Goldman Sachs | Gabriela Borges | $11 | $16.66 | -93.8% | Aug 8, 2023 |
| Wedbush | Daniel Ives | $25 | $16.92 | -86.0% | Jul 28, 2023 |
| RBC Capital | Rishi Jaluria | $5 | $8.59 | -97.2% | Feb 14, 2023 |
| Jefferies | Analyst unavailable | $7.5 | $6.36 | -95.8% | Jan 5, 2023 |
| Wolfe Research | Alex Zukin | $4.5 | $6.31 | -97.5% | Dec 21, 2022 |
| Citigroup | Analyst unavailable | $5 | $7.64 | -97.2% | Nov 11, 2022 |
| Citigroup | Analyst unavailable | $6 | $9.82 | -96.6% | Aug 9, 2022 |
| Jefferies | Analyst unavailable | $12 | $9.82 | -93.3% | Aug 9, 2022 |
| Deutsche Bank | Brad Zelnick | $8 | $9.82 | -95.5% | Aug 9, 2022 |
| Raymond James | Brian Gesuale | $20 | $10.46 | -88.8% | Jul 21, 2022 |
| Goldman Sachs | Gabriela Borges | $10 | $9.01 | -94.4% | Jun 23, 2022 |
| Bank of America Securities | Mariana Perez Mora | $13 | $8.86 | -92.7% | Jun 21, 2022 |
| Deutsche Bank | Brad Zelnick | $11 | $8.34 | -93.8% | May 15, 2022 |
| Morgan Stanley | Keith Weiss | $13 | $7.46 | -92.7% | May 10, 2022 |
| Monness | Brian White | $16 | $7.26 | -91.0% | May 10, 2022 |
| Piper Sandler | Weston Twigg | $14 | $7.46 | -92.1% | May 9, 2022 |
| Piper Sandler | Weston Twigg | $16 | $11.12 | -91.0% | Apr 27, 2022 |
| RBC Capital | Rishi Jaluria | $12 | $11.96 | -93.3% | Apr 25, 2022 |
| Monness | Brian White | $20 | $12.42 | -88.8% | Apr 14, 2022 |
| Piper Sandler | Weston Twigg | $15 | $11.87 | -91.6% | Mar 10, 2022 |
| Morgan Stanley | Keith Weiss | $16 | $11.11 | -91.0% | Mar 7, 2022 |
| Deutsche Bank | Brad Zelnick | $15 | $11.02 | -91.6% | Feb 20, 2022 |
| Wolfe Research | Alex Zukin | $9 | $11.02 | -95.0% | Feb 18, 2022 |
| RBC Capital | Rishi Jaluria | $9 | $11.77 | -95.0% | Feb 17, 2022 |
| Jefferies | Brent Thill | $21 | $12.94 | -88.2% | Feb 4, 2022 |
Track every rating change on PLTR the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationPalantir Technologies Inc. engineers and deploys advanced software platforms primarily for the intelligence community, supporting counterterrorism investigations and operations across the United States, the United Kingdom, and internationally. One such product is Palantir Gotham, a sophisticated software system that enables users to uncover hidden patterns within diverse datasets, from signals intelligence to confidential informant reports. Gotham also facilitates the seamless handover between analysts and operational personnel, helping operators strategize and execute real-world responses to threats pinpointed within the platform.…
Historical context
All PLTR earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| AAPL Apple Inc. | FY2026 Q4 · Calendar Q4 2026 | +3.0% | -1.8% | Apple posts a record quarter as cost and supply pressures persist |
| ON ON Semiconductor Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.5% | -2.2% | ON Semiconductor: AI power demand leads, Q4 outlook upbeat |
| CHKP Check Point Software Technologies Ltd. | FY2026 Q3 · Calendar Q4 2026 | +0.4% | -7.0% | Check Point Sees Q3 as Revenue Trough, While Subscriptions Grow |
| FN Fabrinet | FY2027 Q1 · Calendar Q4 2026 | +3.3% | -3.8% | Fabrinet posts 51% growth as capacity expansion accelerates |
| LSCC Lattice Semiconductor Corporation | FY2026 Q3 · Calendar Q4 2026 | +30.0% | +2.7% | Lattice posts record Q3 as AI-server demand accelerates |
| TSEM Tower Semiconductor Ltd. | FY2026 Q3 · Calendar Q4 2026 | — | -6.7% | Tower Semiconductor Q3: record results, capacity expansion |
Latest beats and misses
Who reports nextBeat on EPS
- CLXFY2027 Q1 · November 2, 2026+44.9% EPS+2.2% move
- AAPLFY2026 Q4 · November 2, 2026+3.0% EPS-1.8% move
- ETRFY2026 Q3 · November 2, 2026+14.5% EPS-0.2% move
- OFY2026 Q3 · November 2, 2026+5.7% EPS+1.1% move
- SBACFY2026 Q3 · November 2, 2026+4.8% EPS-1.2% move
- ONFY2026 Q3 · November 2, 2026+2.5% EPS-2.2% move
Missed on EPS
- VRTXFY2026 Q3 · November 2, 2026-1.2% EPS-1.0% move
- PEGFY2026 Q3 · November 2, 2026-3.4% EPS+0.1% move
- RYAAYFY2027 Q2 · November 2, 2026-0.3% EPS+2.9% move
- GLPIFY2026 Q3 · October 29, 2026-11.5% EPS-1.3% move
- LYBFY2026 Q3 · October 30, 2026-1.2% EPS+5.0% move
- CCJFY2026 Q3 · October 30, 2026-101.4% EPS-7.9% move
Get the PLTR recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-11-03T04:05:10.685762+00:00
- FN2 earnings calendar · 2026-11-03T01:23:13.143323+00:00
- Polygon adjusted daily market bars · 2026-11-03T07:40:51.116005+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-03T07:40:51.113367+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-03. For educational purposes only; not investment advice.